|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 | |
| C12N 15/113 | |||
| A61K 31/7125 | |||
| A61K 31/713 |
| (11) | Number of the document | 2780353 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12850255.6 |
| Date of filing the European patent application | 2012-11-16 | |
| (97) | Date of publication of the European application | 2014-09-24 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/065691 |
| Date | 2012-11-16 |
| (87) | Number | WO 2013/075035 |
| Date | 2013-05-23 |
| (30) | Number | Date | Country code |
| 201161561710 P | 2011-11-18 | US | |
| 201261615618 P | 2012-03-26 | US | |
| 201261680098 P | 2012-08-06 | US |
| (72) |
RAJEEV, Kallanthottathil, G., US
ZIMMERMANN, Tracy, US
MANOHARAN, Muthiah, US
MAIER, Martin, US
KUCHIMANCHI, Satyanarayana, US
CHARISSE, Klaus, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES |
| RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES |